Profile data is unavailable for this security.
About the company
ImmunoPrecise Antibodies Ltd. is a Canada-based biotherapeutic research and technology company. It leverages systems biology, multiomics modelling and artificial intelligence systems to support its technologies in bioplatform-based antibody discovery. Its services include highly specialized, full-continuum therapeutic biologics discovery, development, and out-licensing to support its business partners to discover and develop novel biologics. It utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases. It offers services, such as immunogen design and manufacturing, B cell sorting incorporating its function-first B cell screening and sequencing, and the production and screening of custom, immune, and naive phage display libraries. It also operates LSA instrument platform, which is a provider of high-throughput large and small molecule screening and characterization solutions.
- Revenue in USD (TTM)17.77m
- Net income in USD-20.36m
- Incorporated2016
- Employees102.00
- LocationImmunoprecise Antibodies Ltd3204-4464 Markham St.VICTORIA V8Z 7X8CanadaCAN
- Phone+1 (604) 806-0626
- Fax+1 (250) 483-0309
- Websitehttps://www.ipatherapeutics.com/
Mergers & acquisitions
Acquired company | IPA:NMQ since announced | Transaction value |
---|---|---|
Carterra Inc-LSA Platform | -51.72% | -- |